Regression of pulmonary MALT lymphoma after treatment with rituximab

Leukemia and Lymphoma

Volumn 46, Issue 9, 2005, Pages 1383-1386

  Chong, Elise A ^a   Svoboda, Jakub ^a   Cherian, Sindhu ^a   Andreadis, Charalambos ^a   Downs, Lisa H ^a   Zhuang, Hongming ^a   Alavi, Abass ^a   Tsai, Donald E ^a   Schuster, Stephen J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

MALT; Marginal zone lymphoma; Non Hodgkin's lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG BIOPSY; LUNG CANCER; LYMPHOCYTIC INFILTRATION; MONOTHERAPY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; ANTIBODIES, MONOCLONAL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE;

EID: 24644490145     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500137890     Document Type: Article

References (12)

1. Isaacson PG, Berger F, Müller-Hermelink HK, Nathwani BN, Piris MA, Swerdlow SH, Harris NL. Extranodal marginal zone B-cell lymphoma of mucosal-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp 157-160.
2. Ahmed S, Kussick SJ, Siddiqui AK, Bhuiya TA, Khan A, Sarewitz S, Steinberg H, Sison CP, Rai KR. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004;40:1320-1326.
3. Kurtin PJ, Myers JL, Adlakha H, Strickler JG, Lohse C, Pankratz VS, Inwards DJ. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 2001;25:997-1008.
4. Wislez M, Cadranel J, Antoine M, Milleron B, Bazot M, Mayaud C, Carette MF. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999;14:423-429.
5. Coiffier B. Monoclonal antibodies in the treatment of indolent lymphomas. Best Pract Res Clin Haematol 2005;18(1):69-80.
6. Zinzani PL, Tani M, Gabriele A, Poletti V, Stefoni V, Alinari L, Musuraca G, Bonifazi F, Pileri S, Tura S, Baccarani M. Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients. Leuk Lymphoma 2003;44:821-824.
7. Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, Kim K, Kim WS, Jung CW, Park YS et al. Primary pulmonary non-Hodgkin's lymphoma. Jpn J Clin Oncol 2004;34:510-514.
8. Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A, Marchi E, Pileri S, Baccarani M. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004;100:2190-2194.
9. Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, Ponzoni M, Pedrinis E, Dell'Oro S, Pruneri G et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-2745.
10. Raderer M, Jager G, Brugger S, Puspok A, Fiebiger W, Drach J, Wotherspoon A, Chott A. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003;65(4):306-310.
11. Datta YH, Kampalath B, Binion DG. Rituximab-induced remission of a gastric MALT lymphoma. Leuk Lymphoma 2004;45:1297-1299.
12. Nuckel H, Meller D, Steuhl KP, Duhrsen U. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 2004;73(4):258-262.